intensive care unit Ward Manager Maik Maack Co-Ward Managers Ute Streibing Sven Mc Veigh Telefon for rooms 1-7 +49 (0)511 532-6912 for rooms 8-14 +49 (0)511 532-2122 https://www.mhh.de/pflege/stationen-und-fu

intravenous immunotherapy (high-dose interferon therapy, checkpoint inhibitors such as ipilimumab or PD-1 blockers), venous accesses (brown needles) are inserted and the infusions are connected. The required

in Germany with a congenital heart defect. This most common form of congenital malformation affects 1% of all newborns. With over 40 years of experience, the MHH is one of the most renowned German Clinical

address Postal address (MHH): Hannover Medical School Regulatory Affairs OE 8661, Carl-Neuberg-Str. 1 30625 Hannover Dr. Ute Denkena Team leader Phone: +49 (0) 176 1532 7239 Fax: +49 (0) 511 532 161130

Postal address Postal address (MHH): Hannover Medical School Data Management OE 8661, Carl-Neuberg-Str. 1 30625 Hannover Barbara Neuhaus Team leader Phone: +49 (0) 176 1532 7231 Fax: +49 (0) 511 532 161130

direct PCR screening for footprintless targeted human pluripotent stem cells. Stem Cell Reports 2, no. 1:107

(tomosynthesis, target images, MRI, biopsies) Practical learning of the mammography setting technique (1 working day, in consultation with the MTRAs at the Breast Center) Communication/demonstration of findings

linemia or Bruton disease) Diseases with immune dysregulation (e.g. APDS, APECED, IPEX, STAT3, STAT1, CTLA-4, HLH syndromes like XIAP) Phagocyte defects (e.g. septic granulomatosis, leukocyte adhesion

Medical School Center for Rare Diseases OE 5130 B-Centre for Rare Syndromal Diseases Carl-Neuberg-Str. 1 30625 Hannover zse@mh-hannover.de Further information for patients Further links You can find further

professionals. In addition, the overall coordination of the network will take place here. (Subproject 1, Hanover) We want to identify cancer therapy targets and improve the diagnosis of cancer by studying